pyrimidine has been researched along with Arenaviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chatterjee, AK; Chen, E; Cubitt, B; de la Torre, JC; Hull, MV; Kim, YJ; Kuhn, JH | 1 |
| de la Torre, JC; Devito, S; Eggink, D; Martínez-Sobrido, L; Munger, J; Ngo, N; Ortiz-Riaño, E; Shaw, ML | 1 |
2 other study(ies) available for pyrimidine and Arenaviridae Infections
| Article | Year |
|---|---|
The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Arenaviridae; Arenaviridae Infections; Chlorocebus aethiops; Databases, Pharmaceutical; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Electron Transport Complex III; HEK293 Cells; Humans; Interferons; Junin virus; Lassa virus; Lymphocytic choriomeningitis virus; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrimidines; Vero Cells; Virus Replication | 2019 |
Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Topics: Animals; Antiviral Agents; Arenaviridae Infections; Arenavirus; Cell Line; Drug Evaluation, Preclinical; Humans; Pyrimidines; Virus Replication | 2014 |